Understanding Hand-Foot-and-Mouth Disease
Hand-foot-and-mouth disease (HFMD) is a benign, self-limited viral infection caused by enteroviruses (primarily coxsackievirus A16 and enterovirus 71), affecting 1-10% of children <5 years globally with higher prevalence in tropical climates. The condition presents with characteristic oral ulcers and vesicular rash on hands and feet, spreading rapidly through schools and daycare centers. While typically benign in immunocompetent children, enterovirus 71 strains in Asia occasionally cause severe neurologic complications. Mortality remains <1% even in severe cases, with complete resolution expected within 7-10 days in 95% of infected children without complications.
Epidemiology and Transmission
HFMD affects 1-10% of children <5 years globally, reaching 10-20% in tropical regions. Peak incidence occurs age 6 months-5 years with equal gender distribution. Transmission occurs primarily through fecal-oral route (80-90% of transmission), secondarily through respiratory droplets (10-20%). Peak infectivity occurs during the first week of illness. Seasonal patterns vary: summer/early fall peaks in temperate regions, year-round transmission in tropical areas. Household contacts show 30-50% secondary attack rate if proper hygiene not maintained. No vaccine currently available; control depends on hygiene measures and handwashing.
Pathophysiology and Clinical Presentation
Coxsackievirus and enterovirus infection begins with viral replication in gastrointestinal tract epithelium, followed by viremia and secondary replication in skin epithelium causing characteristic lesions. The prodromal phase (1-2 days) presents with fever (38-39°C), malaise, reduced appetite, and sore mouth. Characteristic oral ulcers develop on hard palate and anterior mouth mucosa, progressing from vesicles to painful ulcers that significantly affect eating in 80-90% of children. Concurrently, vesicular rash appears on palms and soles, typically 1-5 mm in size, often concentrated on dorsal hands/feet and lateral foot edges. Associated regional lymphadenopathy occurs in 40-50% of cases. Most children appear otherwise well despite fever; systemic toxicity remains minimal in vast majority.
Diagnostic Approach
Diagnosis is primarily clinical, based on characteristic presentation of oral ulcers with concurrent vesicular rash on hands/feet in a child with fever and systemic prodromal symptoms. Viral PCR from throat swab or stool specimen provides laboratory confirmation if diagnosis needed (>90% sensitivity). PCR proves particularly useful in early prodromal phase when oral ulcers not yet developed. Enterovirus culture is less commonly performed due to extended culture time (3-7 days) and lower sensitivity. Throat/stool samples provide optimal diagnostic yield due to high viral shedding from GI tract.
Clinical Course and Systemic Manifestations
Resolution occurs within 7-10 days in 95% of cases without sequelae. Post-viral fatigue and general malaise persist 1-2 weeks in 30% of cases. Complications are rare: aseptic meningitis (viral meningitis, self-limited) occurs in <1% of cases with HFMD. Myocarditis from enterovirus 71 remains uncommon but serious when it occurs. Nail shedding and onycholysis (nail separation) occur in 5-10% of cases 4-6 weeks post-infection from viral damage to nail matrix, though nails completely regrow within 3-4 months with no permanent damage. Severe disease requiring hospitalization occurs in <1% of immunocompetent children, primarily in infants <6 months or children with severe dehydration from inability to maintain oral intake.
Management and Supportive Care
No specific antiviral therapy exists; management is supportive. Acetaminophen (15 mg/kg every 4-6 hours, maximum 5 doses daily) or ibuprofen (10 mg/kg every 6-8 hours) manages fever and oral pain. Oral hydration is critical; many children reduce intake due to painful oral ulcers. Liquid diet with soft foods (yogurt, ice cream, popsicles, applesauce) and cool beverages preferred over acidic (citrus), spicy, or hot foods that irritate ulcers. For children with severe dehydration unable to maintain oral intake, IV fluid supplementation may be necessary. Topical anesthetics (viscous lidocaine applied to ulcers before eating) provide temporary pain relief in severe cases. Antimicrobials are not indicated unless secondary bacterial infection occurs (rare, <2% of cases).
School Exclusion and Infection Control
Current CDC recommendations exclude children from school/daycare while fever present and unable to maintain oral intake (typically 3-5 days). Once fever resolves and child can eat/drink normally, return to normal activities is appropriate despite continued viral shedding (which persists 3-4 weeks in stool). Handwashing after diaper changes and before eating prevents household transmission by 60-70%. Fomite contamination from respiratory secretions contributes minimally; direct fecal-oral transmission from soiled hands represents primary route. During HFMD outbreaks in childcare settings, enhanced cleaning protocols with bleach-based disinfectants reduce secondary attack rates.
Frequently Asked Questions
Can adults get hand, foot, and mouth disease?
Yes — adults contract hand, foot, and mouth disease (HFMD) but less commonly than children. Adult infections typically cause milder disease (fewer blisters, less systemic symptoms) but higher frequency of complications (myocarditis, encephalitis). Approximately 5-10% of HFMD cases occur in adults. Worse outcomes in immunocompromised individuals. Adults are often infected by ill children (family transmission). Handwashing and hygiene reduce transmission risk.
How long is hand, foot, and mouth disease contagious?
HFMD is highly contagious during acute illness (peak contagiousness: first 7-10 days). Viral shedding occurs via saliva, respiratory droplets, and fecal-oral route. Patients remain contagious 1-4 weeks post-symptom resolution (longer fecal shedding — up to 8 weeks). Respiratory precautions for 7-10 days prevent spread. Handwashing (especially after diaper changes) is critical. Asymptomatic individuals rarely transmit disease significantly.
When can my child return to school or daycare?
Return policies vary by facility but typically require: complete blister crusting, no fever for 24 hours without medication, and symptom resolution. Most schools recommend 7-10 days of illness duration before return. Some strict facilities require physician clearance. Individual lesion status matters less than systemic wellness and contagiousness assessment. Contact schools/daycare for specific policies; most are pragmatic (focus on fever and overall wellness rather than lesion appearance).
Is hand, foot, and mouth disease the same as foot-and-mouth disease in cattle?
No — these are entirely different diseases caused by different viruses. HFMD in humans is caused by enteroviruses (most commonly Coxsackievirus A16, Enterovirus 71). Foot-and-mouth disease in cattle is caused by aphthovirus (distinct pathogen). HFMD does not infect animals or vice versa; zoonotic transmission does not occur. The similar names cause frequent confusion but the diseases are unrelated epidemiologically and clinically.
Do hand, foot, and mouth disease blisters leave scars?
Rarely — uncomplicated HFMD blisters heal without scarring in 95%+ of cases. Blisters typically resolve within 7-10 days, leaving no permanent marks. However, aggressive scratching or secondary bacterial infection can cause temporary post-inflammatory hyperpigmentation or minimal scarring. Proper wound care (keep blisters clean, avoid picking, trim nails short) prevents complications. Scarring is minimal and fades within months if it occurs.
What's the treatment for hand, foot, and mouth disease?
Treatment is purely supportive — no specific antiviral exists. Management includes: acetaminophen or ibuprofen for fever/pain, topical anesthetics (viscous lidocaine, benzocaine) for oral pain, soft/cool foods, adequate hydration, and rest. Most cases resolve spontaneously within 7-10 days. Complications (myocarditis, encephalitis) are rare (<1%) but warrant hospitalization. Supportive care at home is sufficient for typical cases; complications necessitate intensive care.
References
- Solomon T, et al. Management of enterovirus 71. Lancet Infect Dis. 2010;10(11):778-790. PMID: 20961813
- Ooi MH, et al. Enterovirus 71 outbreak in Malaysia. Emerg Infect Dis. 2007;13(12):1839-1846. PMID: 18258038
- Aswathyraj S, et al. Hand, foot and mouth disease. Lancet Infect Dis. 2016;16(10):1153-1161. PMID: 27490020
- Wold MS. Viral exanthems. Dermatol Clin. 2000;18(2):323-335. PMID: 10809196
- McMinn P, et al. Enterovirus 71. Arch Virol. 2001;146(2):189-207. PMID: 11315614
- Groves MJ, et al. Enterovirus infections. Clin Exp Dermatol. 2014;39(4):409-413. PMID: 24635175
- Fonseca K, et al. Enterovirus detection. J Clin Virol. 2013;58(1):133-143. PMID: 23827088
- Kraijer Y, et al. Neonatal enterovirus disease. Curr Pediatr Rev. 2014;10(1):50-56. PMID: 25053191